POLYMORPHS OF BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS AND USES THEREOF

BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM

NEW BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM

METHODS OF PREPARING CHIRAL BENZODIAZEPINONE DERIVATIVES

BENZODIAZEPINE ANALOGS AND METHODS OF USE IN TREATING CANCER

DEUTERATED BENZODIAZEPINE ANALOGS AND METHODS OF USE IN TREATING CANCER

NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE

COMPOSITIONS AND METHODS FOR REDUCING TACTILE DYSFUNCTION, ANXIETY, AND SOCIAL IMPAIRMENT

POLYMORPHS OF BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS AND USES THEREOF

NEW BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM

METHODS OF PREPARING CHIRAL BENZODIAZEPINONE DERIVATIVES

Combination pharmaceutical agents as RSV inhibitors

Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Crystalline form of propoxazepam, the method of its making and use as medicinal agent

COMPOSITIONS COMPRISING SHORT-ACTING BENZODIAZEPINES

Inhibition of respiratory complex III by ligands that interact with a regulatory switch

PERIPHERALLY RESTRICTED GABA POSITIVE ALLOSTERIC MODULATORS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME AND OTHER AILMENTS OF THE PERIPHERAL NERVOUS SYSTEM

Antiviral benzodiazepine compounds

1,4-benzodiazepin-2-one derivatives and use thereof

Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system

Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system

1,3-dihydro-1,4-benzodiazepine-2-thiones for the treatment of CNS related diseases

Combination pharmaceutical agents as RSV inhibitors

Therapeutic compounds and uses thereof

Compounds Which Have a Protective Activity with Respect to the Action of Toxins and of Viruses with an Intracellular Mode of Action

Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system

Fused heterocyclic compounds as ion channel modulators

Benzodiazepine derivatives for use in the treatment of Chlamydiales infections

Fused heterocyclic compounds as ion channel modulators

BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS

BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS

Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds

Prodrugs of 1,4-benzodiazepinone compounds

Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds

Fluoroalkyl-1,4-benzodiazepinone compounds

Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof

Benzodiazepine compounds with anti-flavivirus activity

BIS(FLUOROALKYL)-1,4-BENZODIAZEPINONE COMPOUNDS

Fused heterocyclic compounds as ion channel modulators

Bisfluoroalkyl-1,4-benzodiazepinone compounds

Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof

Inhibitors of the shiga toxins trafficking through the retrograde pathway

Therapeutic applications of pro-apoptotic benzodiazepines

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

Benzodiazepinone compounds useful in the treatment of skin conditions

Compositions and methods for inhibiting the proliferation of cells

P2Xreceptor antagonist

Fused heterocyclic compounds as ion channel modulators

Compositions And Methods Relating To Novel Compounds And Targets Thereof

Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action

Bisfluoroalkyl-1,4-benzodiazepinone compounds

Benzodiazepinone compounds and methods of treatment using same

COMPOSITIONS AND METHODS RELATING TO NOVEL COMPOUNDS AND TARGETS THEREOF

P2X4 RECEPTOR ANTAGONIST

UNSOLVATED BENZODIAZEPINE COMPOSITIONS AND METHODS

Benzodiazepinone compounds useful in the treatment of skin conditions

1,4-BENZODIAZEPIN-2-ON DERIVATIVES

Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof

Inhibitors of the Shiga toxins trafficking through the retrograde pathway

INHIBITORS OF HISTONE DEACETYLASE

Compositions and methods relating to novel compounds and targets thereof

CHEMICAL COMPOUNDS

Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof

5-phenyl-1H-benzo [E] [1,4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors

Selective agents for pain suppression

P2X4 RECEPTOR ANTAGONIST

ANTICONVULSANT AND ANXIOLYTIC METHODS OF USING RECEPTOR SUBTYPE SELECTIVE AGENTS

SUBSTITUTED LACTAMS AS INHIBITORS OF A BETA PROTEIN PRODUCTION

SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION

SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION

CYCLIC MALONAMIDES AS INHIBITORS OF A BETA PROTEIN PRODUCTION

Benzodiazepine derivatives and pharmaceutical compositions containing them

SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION

CYCLIC MALONAMIDES AS INHIBITORS OF ABETA PROTEIN PRODUCTION

Compositions and methods relating to novel compounds and targets thereof

STEREOSPECIFIC ANXIOLYTIC AND ANTICONVULSANT AGENTS WITH REDUCED MUSCLE-RELAXANT, SEDATIVE-HYPNOTIC AND ATAXIC EFFECTS

Benzodiazepine derivatives for treating hepatitis C infection

CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION

Unsolvated benzodiazepine compositions and methods

Compounds, preparation and therapeutic use thereof

Registry method and control system for DEA schedule II-V medicines

Process for preparing pyrazole functionalized benzodiazepinones

Substituted lactams as inhibitors of Aβ protein production

Salts and crystal modifications thereof

SUBSTITUTED BENZYL AMINE COMPOUNDS

Benzodiazepinone compounds useful in the treatment of skin conditions

HYDROXYALKANOYLAMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF A BETA PROTEIN PRODUCTION

SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF AB PROTEIN PRODUCTION

LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION

Therapeutic applications of pro-apoptotic benzodiazepines

Compositions and Methods Relating to Novel Compounds and Targets Thereof

Succinoylamino lactams as inhibitors of a-β protein production

Cyclic malonamides as inhibitors of aβ protein production

Compositions and methods relating to novel compounds and targets thereof

Dihydro-benzo[B][1,4]diazepin-2-one sulfonamide derivatives

Substituted lactams as inhibitors of Aβ protein production

Succinoylamino benzodiazepines as inhibitors of aβ protein production

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Abeta PROTEIN PRODUCTION

Benzodiazepines for Treating or Preventing Rsv Infection

Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein production

ANXIOLYTIC AGENTS WITH REDUCED SEDATIVE AND ATAXIC EFFECTS

Lactams substituted by cyclic succinates as inhibitors of Aβ protein production

Asthma and allergic inflammation modulators

Soluble 1,4 benzodiazepine compounds and stable salts thereof

Substituted benzyl amine compounds

Cyclic malonamides as inhibitors of Aβ protein production

Compostions and methods relating to novel compounds and targets thereof

Anxiolytic Agents With Reduced Sedative And Ataxic Effects

Process for Preparing Benzodiazepines

Tetraazabenzo[e]azulene derivatives and analogs thereof

Novel 3-substitued-1,4-benzodiazepines

Substituted lactams as inhibitors of Aβ protein production

Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase

Compositions and methods for inhibiting the proliferation of cells

Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof

Substituted n-phenyl sulfonamide bradykinin antagonists

Anxiolytic agents with reduced sedative and ataxic effects

ANXIOLYTIC AGENTS WITH REDUCED SEDATIVE AND ATAXIC EFFECTS

Unsolvated benzodiazepine compositions and methods

Therapeutic applications of pro-apoptotic benzodiazepines

Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production

Succinoylamino lactams as inhibitors of Aβ protein production

Succinoylamino lactams as inhibitors of Aβ protein production

Novel compounds useful for bradykinin B1 receptor antagonism

Substituted lactams as inhibitors of Abeta protein production

Cyclic malonamides as inhibitors of Aβ protein protection

Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses

Succinoylamino benzodiazepines as inhibitors of Aβ protein production

Benzodiazepine derivatives and pharmaceutical compositions containing them

Cell adhesion inhibitors

Succinoylaminobenzodiazepines as inhibitors of Aβ protein production

Water-soluble derivatives of lipophilic drugs

Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects

Tetraazabenzo[e]azulene derivatives and analogs thereof

Protein kinase inhibitors

Lactams substituted by cyclic succinates as inhibitors of Aβ protein production

Compositions and methods relating to novel compounds and targets thereof

Succinoylamino lactams as inhibitors of A-β protein production

Substituted lactams as inhibitors of Aβ protein production

Benzodiazepine derivatives, preparation thereof and use thereof

Benzo-fused heterocycles as endothelin antagonists

Compositions and methods relating to novel compounds and targets thereof

Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production

Carbamic acid alkyl ester derivatives

Malonamide derivatives

Cyclic malonamides as inhibitors of A-β protein production